Sponsor · clinical trials

Centre Hospitalier Universitaire de Nice clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine and the EU Clinical Trials Information System (CTIS) — current trials in our France, Canada, Spain, Italy, Netherlands, Belgium and EU (CTIS) registers with Centre Hospitalier Universitaire de Nice as lead sponsor. Synced 11 Nov 2026

201Current trials

119Recruiting now

28Drugs in these trials

7Trial registers

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 11 Nov 2026 · Editorial standards

At a glance

Centre Hospitalier Universitaire de Nice is the lead sponsor of 201 current clinical trials in our France, Canada, Spain, Italy, Netherlands, Belgium and EU (CTIS) registers. 119 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Amiloride, Amoxicillin and Bimekizumab. The most-studied condition is Aging.

ClinicalTrials.gov trials by status

Recruiting11960%
Not yet open3719%
Active, closed3920%
By invitation32%

Trials by phase

Not applicable11257%
Observational6131%
Phase 2105%
Phase 484%
Phase 342%
Phase 2/332%

Clinical trials sponsored by Centre Hospitalier Universitaire de Nice

198 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months NCT06815133 · ClinicalTrials.gov ↗ · Myasthenia Gravis	Observational	Recruiting	2025-03	France
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery NCT06278285 · ClinicalTrials.gov ↗ · Obesity	Not applicable	Recruiting	2024-03	France
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients NCT06447480 · ClinicalTrials.gov ↗ · Acne Vulgaris Drug: Isotretinoin	Phase 3	Recruiting	2025-04	France
Upstroke Time Measured by Photoplethysmography NCT05795582 · ClinicalTrials.gov ↗ · Diabetes	Not applicable	Recruiting	2023-06	France
Effect of the French Version If the Metagognitive Bibliotherapy Program "MYMCT" on Obsessive-compulsive Symptoms NCT06494735 · ClinicalTrials.gov ↗ · Obsessive-Compulsive Disorder	Not applicable	Recruiting	2024-09	France
INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR NCT07499869 · ClinicalTrials.gov ↗ · Temporomandibular Disorders (TMD)	Not applicable	Recruiting	2026-09	France
Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021) NCT04923087 · ClinicalTrials.gov ↗ · Frailty, Malnutrition, Anorexia	Observational	Recruiting	2021-06	France
Evaluation of Urinary Dysfunction in CANVAS Patients NCT06817707 · ClinicalTrials.gov ↗ · Cerebellar Ataxia, Neuropathy, Vestibular Areflexia	Not applicable	Recruiting	2025-03	France
Effects of Transcranial Direct Current Stimulation (tDCS) on Inhibition and Brain Function in Primary Progressive Aphasia NCT06473714 · ClinicalTrials.gov ↗ · Aphasia, Primary Progressive	Not applicable	Recruiting	2024-11	France
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression NCT06079567 · ClinicalTrials.gov ↗ · Facioscapulohumeral Muscular Dystrophy Type 2	Not applicable	Recruiting	2023-10	France, Spain, Italy, Netherlands, Belgium
Quality of Life-Guided Transfusion in Refractory MDS or AML NCT07328191 · ClinicalTrials.gov ↗ · MDS, AML, Adult, Anemia	Not applicable	Recruiting	2026-02	France
Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis, NCT07529236 · ClinicalTrials.gov ↗ · Chronic Inflammatory Bowel Diseases	Not applicable	Recruiting	2026-04	France
Diagnostic Value of eVOG NCT05776511 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Radiologically Isolated Syndrome, White Matter Lesions	Not applicable	Recruiting	2023-04	France
Inflatable Penile Prostheses : Which Patients Can Correctly Use the Scrotal Pump ? NCT04390230 · ClinicalTrials.gov ↗ · Surgery, Satisfaction, Penile Prosthesis; Complications	Observational	Recruiting	2014-01	France
Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance. NCT05346627 · ClinicalTrials.gov ↗ · Mitochondrial Myopathies	Not applicable	Recruiting	2022-12	France
Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic NCT05056740 · ClinicalTrials.gov ↗ · Central Nervous System Diseases	Observational	Recruiting	2020-06	France
Videographic Feedback and Walk Rehabilitation in Post-Cerebrovascular Accident NCT05024981 · ClinicalTrials.gov ↗ · Cerebrovascular Accident	Not applicable	Recruiting	2022-03	France
From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP NCT04174066 · ClinicalTrials.gov ↗ · Nephrotic Syndrome	Observational	Recruiting	2020-05	France
Purinergic Compounds in Pseudoxanthoma Elasticum NCT07323082 · ClinicalTrials.gov ↗ · Pseudoxanthoma Elasticum	Not applicable	Recruiting	2026-01	France
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized NCT06509984 · ClinicalTrials.gov ↗ · Epidermolysis Bullosa Simplex, Genodermatosis	Phase 2	Recruiting	2024-08	France
RIS International Cohort NCT05388331 · ClinicalTrials.gov ↗ · Multiple Sclerosis, Radiologically Isolated Syndrome	Observational	Recruiting	2022-04	France
Comparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE NCT07835945 · ClinicalTrials.gov ↗ · Pulmonary Disease (COPD), Chronic Obstructive	Not applicable	Recruiting	2026-09	France
Integrating Artificial Intelligence Into Lung Cancer Screening. NCT05704920 · ClinicalTrials.gov ↗ · Lung Cancer	Not applicable	Recruiting	2024-04	France
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2 NCT07074418 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases	Phase 4	Recruiting	2026-08	France
Persistent Organic Pollutants and Mechanical Discharge: Limiting the Impact of Bariatric Surgery Through Personalized Adapted Physical Activity NCT06597617 · ClinicalTrials.gov ↗ · Obesity, Bariatric Surgery Candidate	Not applicable	Recruiting	2025-06	France
Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML) NCT03280888 · ClinicalTrials.gov ↗ · Chronic Myelomonocytic Leukemia	Observational	Recruiting	2014-11	France
Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students NCT07266857 · Papillomavirus Infection, Papillomavirus Vaccines, Vaccination Coveage	Observational	Recruiting	2025-05	France
Role of Circulating Pyrophosphate as a Biomarker of Mediacalcinosis in Type 2 Diabetic Patients NCT07005986 · ClinicalTrials.gov ↗ · Type 2 Diabetes, Type 2 Diabetes Patients	Not applicable	Recruiting	2025-06	France
Study of the Incidence of SARS-CoV-2 Infection (COVID-19) NCT04429594 · ClinicalTrials.gov ↗ · Coronavirus Infections	Not applicable	Recruiting	2020-07	France
IL17 Rate and Spondyloarthritis NCT05592574 · ClinicalTrials.gov ↗ · Spondylarthritis	Observational	Recruiting	2021-02	France
Evaluation of the Efficacy of Pulmonary Vein Isolation by Pulsed-field Ablation in Persistent Atrial Fibrillation: a Multicenter Study With Follow-up by Implantable Cardiac Monitor NCT06985901 · ClinicalTrials.gov ↗ · Persistent Atrial Fibrillation	Not applicable	Recruiting	2026-04	France
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15 NCT03893643 · ClinicalTrials.gov ↗ · Neurofibromatosis 2, Dermatology/Skin - Other	Observational	Recruiting	2019-01	France
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy NCT04326218 · ClinicalTrials.gov ↗ · Membranous Nephropathy	Not applicable	Recruiting	2020-07	France
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma NCT05307289 · ClinicalTrials.gov ↗ · Melanoma (Skin)	Not applicable	Recruiting	2022-05	France
E-CANE: a National Program of Remote Health Education Workshops NCT06748820 · ClinicalTrials.gov ↗ · Neoplasms	Observational	Recruiting	2025-01	France
Friedreich Ataxia Nerve Ultrasund NCT07508631 · ClinicalTrials.gov ↗ · Friedreich Ataxia	Observational	Recruiting	2025-12	France
Thromboxane A2 and Osteoarthritis NCT05593640 · ClinicalTrials.gov ↗ · Osteoarthritis	Observational	Recruiting	2022-09	France
Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals NCT06973174 · ClinicalTrials.gov ↗ · Sepsis, Infections	Observational	Recruiting	2010-01	France
Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders NCT06597591 · ClinicalTrials.gov ↗ · Cognitive Disorder	Not applicable	Recruiting	2024-11	France
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics NCT05260528 · ClinicalTrials.gov ↗ · Acute Myeloid Leukemia	Phase 2	Recruiting	2023-05	France
Prognostic Value of Capillary Lactatemia in Potentially Severe Polytrauma Patients NCT06969404 · ClinicalTrials.gov ↗ · Polytrauma	Not applicable	Recruiting	2026-02	France
Real-Life Evaluation of Guselkumab Dosing Interval Adjustments NCT07430319 · ClinicalTrials.gov ↗ · Psoriasis Drugs: Guselkumab, Tremfya	Observational	Recruiting	2025-10	France
Neurocognitive Impairment After Ischemic Stroke NCT06262529 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke	Not applicable	Recruiting	2024-02	France
Superficial Vein Thrombosis of the Upper Limb in Bacteremia Associated With PICCline and Midline Catheters: Frequency and Clinical Consequences NCT07388381 · ClinicalTrials.gov ↗ · Catheter Associated Infection	Not applicable	Recruiting	2026-02	France
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX) NCT06341205 · ClinicalTrials.gov ↗ · Membranous Nephropathy Drug: Rituximab	Phase 3	Recruiting	2025-02	France
Combating the Diagnostic Impasse in Mitochondrial Diseases: a Transcriptomic Approach in Fibroblasts and Blood Cells NCT06621732 · ClinicalTrials.gov ↗ · Mitochondrial Diseases	Not applicable	Recruiting	2025-01	France
Sleep Longitudinal Exploration of the Experience of Patients NCT06888427 · ClinicalTrials.gov ↗ · Sleep	Observational	Recruiting	2025-04	France
Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors NCT05649683 · ClinicalTrials.gov ↗ · Melanoma (Skin)	Not applicable	Recruiting	2023-01	France
Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab) NCT07570589 · ClinicalTrials.gov ↗ · Generalized Myasthenia Gravis	Observational	Recruiting	2026-06	France
Nalysis of the Periodontal Microbiota in Elderly Subjects With and Without Alzheimer's Disease: a Case Control Study NCT05077618 · ClinicalTrials.gov ↗ · Periodontitis, Alzheimer Disease	Observational	Recruiting	2023-01	France
Hemodynamic Impact of the Administration of PAracetamol in Patients Hospitalized in the Intensive Resuscitation Medicine Department [PAREA] NCT06430697 · ClinicalTrials.gov ↗ · Intensive Care Unit Syndrome	Not applicable	Recruiting	2025-02	France
Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications NCT07201649 · ClinicalTrials.gov ↗ · Liver Cirrhosis	Not applicable	Recruiting	2025-11	France
Systolic Function and Weaning-induced Pulmonary Edema (SystoWean Study) NCT05226247 · ClinicalTrials.gov ↗ · Mechanical Ventilation Complication, Pulmonary Edema	Not applicable	Recruiting	2022-08	France
Identify a Specific Immune Profile in Patients With Chronic Pelvic Pain Resistant to First-line Treatments by Measuring Th1, Th2, Th17, and Treg Cytokines Produced After Non-specific Functional Cell Stimulation - ImmunoCPP NCT07429773 · ClinicalTrials.gov ↗ · Endometriosis, Chronic Pelvic Pain Syndrome	Not applicable	Recruiting	2026-04	France
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders NCT07037732 · ClinicalTrials.gov ↗ · Autoimmune Cytopenia, Connective Tissue Disorder, Systemic Vasculitis	Observational	Recruiting	2025-06	France
Population-based Cancer Observatory NCT03687151 · ClinicalTrials.gov ↗ · Cancer	Observational	Recruiting	2005-01	France
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma NCT06112522 · ClinicalTrials.gov ↗ · Cell Carcinoma Drug: Tirbanibulin	Phase 2	Recruiting	2024-02	France
Study of the Metabolism in the Lymphatic Niche of CLL NCT05610228 · ClinicalTrials.gov ↗ · CLL	Observational	Recruiting	2018-11	France
Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA) NCT05943834 · ClinicalTrials.gov ↗ · Neurocognitive Disorders	Observational	Recruiting	2023-07	France
Study of the Location of Motor Cortical Stimulation Electrodes in Chronic Neuropathic Refractory Patients NCT06216717 · ClinicalTrials.gov ↗ · Neuropathic Pain	Observational	Recruiting	2023-11	France
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome NCT06831253 · ClinicalTrials.gov ↗ · Severe Dry Eye Syndromes, Dry Eye Syndromes	Not applicable	Recruiting	2025-03	France
Same Day Ambulatory Appendectomy (SAMBA) NCT05691348 · ClinicalTrials.gov ↗ · Appendicitis	Not applicable	Recruiting	2023-07	France
Nice Human Immunodeficiency Virus (HIV) Cohort NCT03690063 · ClinicalTrials.gov ↗ · Human Immunodeficiency Virus	Observational	Recruiting	1996-01	France
Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments NCT07501507 · ClinicalTrials.gov ↗ · Erosive Hand Osteoarthritis Drug: Methotrexate	Phase 2/3	Recruiting	2026-09	France
Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis NCT07411963 · ClinicalTrials.gov ↗ · Myasthenia Gravis	Observational	Recruiting	2025-11	France
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid NCT06291350 · ClinicalTrials.gov ↗ · Pemphigoid, Benign Mucous Membrane, Gingivitis Hyperplastic	Observational	Recruiting	2024-10	France
Review of the Literature and Serie of Patients Who Underwent Reconstruction After Wide Local Excision of Nail Apparatus for Melanoma NCT06861023 · ClinicalTrials.gov ↗ · Melanoma	Observational	Recruiting	2025-01	France
Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease NCT06300788 · ClinicalTrials.gov ↗ · Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control	Not applicable	Recruiting	2024-05	France
Inelastic Compression in Edema After Revascularization NCT05910411 · ClinicalTrials.gov ↗ · Lymphedema	Not applicable	Recruiting	2023-12	France
Qualitative Study Among Migrant and Socially Vulnerable Populations on Their Interest in Collective Approaches to Health Promotion. NCT07174154 · ClinicalTrials.gov ↗ · Health Promotion, Vulnerable Populations, Access to Health Care	Observational	Recruiting	2025-06	France
A Mixed Intervention to Improve Resilience for Patient With Neurocognitive Disorders NCT06801171 · ClinicalTrials.gov ↗ · Cognitive Disorder	Not applicable	Recruiting	2025-04	France
Preparation for Medical and Surgical Procedures in Oncogeriatry. NCT06443138 · ClinicalTrials.gov ↗ · Geriatric Oncology	Not applicable	Recruiting	2026-09	France
Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY NCT05962827 · ClinicalTrials.gov ↗ · Lymphedema	Not applicable	Recruiting	2023-12	France
MITOMICS : a Multi-OMICS Approach for the Diagnosis of Mitochondrial Diseases NCT04920812 · ClinicalTrials.gov ↗ · Mitochondrial Diseases	Observational	Recruiting	2022-03	France
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy NCT05379738 · ClinicalTrials.gov ↗ · Haematological Malignancy	Not applicable	Recruiting	2022-06	France
Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy NCT03888950 · ClinicalTrials.gov ↗ · Metastatic Melanoma	Not applicable	Recruiting	2020-11	France
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod NCT07072988 · ClinicalTrials.gov ↗ · Myasthenia Gravis, Generalized Drug: Efgartigimod	Phase 4	Recruiting	2025-09	France
Prediction of the Spontaneous Breathing Test Success Using Biosignal and Biomarker in Critical Care Unit by a Machine Learning Approach NCT05886803 · ClinicalTrials.gov ↗ · Weaning From Mechanical Ventilation in Care Unit	Observational	Recruiting	2023-01	France
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo NCT07152626 · ClinicalTrials.gov ↗ · Vitiligo Drug: Litfulo	Phase 2	Recruiting	2026-03	France
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura NCT04063540 · ClinicalTrials.gov ↗ · Migraine With Aura Drug: Amiloride	Phase 2	Recruiting	2020-08	France
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination NCT07135752 · ClinicalTrials.gov ↗ · Radiologically Isolated Syndromes; Multiple Sclerosis	Not applicable	Recruiting	2026-01	France
Feasibility of Using the "CGM GUARDIAN 2" Interstitial Fluid Glucose Measurement System in Intensive Care Medicine NCT04910841 · ClinicalTrials.gov ↗ · Hyperglycemia, Hypotension, Shock, Septic	Not applicable	Recruiting	2023-09	France
Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors. NCT07392437 · ClinicalTrials.gov ↗ · Diabetes Mellitus, Psychological Distress	Not applicable	Recruiting	2026-04	France
Exploratory Evaluation of the BiP Inhibitor BPR001-615 in Primary Cells and the Diagnostic Value of Circulating BiP in Colorectal Adenocarcinomas NCT07813884 · ClinicalTrials.gov ↗ · Colorectal Adenocarcinoma	Not applicable	Recruiting	2026-10	France
MICROBIOTA AND BLADDER CANCER NCT07080333 · ClinicalTrials.gov ↗ · Bladder (Urothelial, Transitional Cell) Cancer	Not applicable	Recruiting	2026-03	France
Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity NCT05343286 · ClinicalTrials.gov ↗ · Elderly	Not applicable	Recruiting	2022-04	France
Early Functional Proprioceptive Stimulation Post-stroke NCT06192953 · ClinicalTrials.gov ↗ · Stroke (CVA) or TIA	Not applicable	Recruiting	2024-05	France
Assessment of Chilbains Occuring During Covid-19 Infection NCT04344119 · ClinicalTrials.gov ↗ · Skin Manifestations, COVID, Chilblains	Observational	Recruiting	2020-04	France
Fluid Administration in Ketoacidosis (DRINK) NCT06541535 · ClinicalTrials.gov ↗ · Diabetic Keto-acidosis	Phase 4	Recruiting	2025-11	France
Assessment of Intra-abdominal Pressure During the Perioperative Period of Hernia Repair NCT07531615 · ClinicalTrials.gov ↗ · Hernia Incisional	Not applicable	Recruiting	2026-07	France
Benefit of Hypnosis on Smartphone for Acute Post-operative Pain (HYPNO-APP) NCT05854914 · ClinicalTrials.gov ↗ · Appendicitis With Peritonitis	Not applicable	Recruiting	2025-06	France
Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections NCT05902221 · ClinicalTrials.gov ↗ · Infections Joint Prosthetic Drugs: Amoxicillin, Moxifloxacin, Rifampicin	Phase 3	Recruiting	2024-05	France
METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX) NCT05821517 · ClinicalTrials.gov ↗ · Anterior Shoulder Dislocation	Phase 4	Recruiting	2023-12	France
PPI Supplementation to Fight ECtopIc Calcification in PXE NCT04868578 · ClinicalTrials.gov ↗ · Pseudoxanthoma Elasticum	Not applicable	Recruiting	2022-12	France
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis NCT05399433 · ClinicalTrials.gov ↗ · Psoriasis	Not applicable	Recruiting	2022-06	France
Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study. NCT07492251 · ClinicalTrials.gov ↗ · Lichen Penis Planus Drug: Upadacitinib	Phase 2	Recruiting	2026-10	France
Inflammatory Dynamics of Innate Immune Cells NCT07633327 · ClinicalTrials.gov ↗ · Peritoneal Lavage	Observational	Recruiting	2026-06	France
Characterization of the Mechanisms of Resistance to Azacitidine NCT01210274 · ClinicalTrials.gov ↗ · Myelodysplastic Syndromes or Acute Myeloid Leukemia With Multilineage Dysplasia	Observational	Recruiting	2010-09	France
Study of Electrophysiological Markers Related to the Cognitive and Affective Processes Behind Empathic Behaviour in Schizophrenic Spectrum Disorder NCT04278339 · ClinicalTrials.gov ↗ · Schizophrenia	Not applicable	Recruiting	2020-10	France
Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots NCT05817786 · ClinicalTrials.gov ↗ · Neuralgia	Not applicable	Recruiting	2024-02	France

Showing the 100 most recently updated of 198 trials (recruiting first). The rest are in the country registers linked in each row.

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Centre Hospitalier Universitaire de Nice in the EU trials register (CTIS)

3 trials

Authorised or ongoing trials in the EU Clinical Trials Information System with Centre Hospitalier Universitaire de Nice as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.

Study	Phase	Status	Countries
A pilot multicentric open study assessing the efficacy and safety of NEMOlizumab in patients ≥12yo with Dystrophic Epidermolysis bullosa; NEMODE 2026-526417-28-00 · CTIS ↗ · Skin and Connective Tissue Diseases Drug: Nemolizumab	Phase 2	Authorised	France
Non-inferiority study of TOCILIZUMAB in dose-banding versus dose-weight in rheumatoid arthritis with low activity or clinical remission 2025-522319-41-00 · CTIS ↗ · Musculoskeletal Diseases Drug: Tocilizumab	Phase 4	Authorised	France
MitOxyVit: Mitochondrial network modulation approach using hyperbaric oxygen (HBO) therapy and NNbUVB for treating vitiligo 2025-524709-34-00 · CTIS ↗ · Skin and Connective Tissue Diseases	Phase 2	Authorised	France

Drugs in Centre Hospitalier Universitaire de Nice trials

28 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Conditions in Centre Hospitalier Universitaire de Nice trials

240 conditions

Aging4 Multiple Sclerosis3Membranous Nephropathy3Psoriasis3 Alzheimer Disease3 Myasthenia Gravis2 Obesity2 Diabetes2 Obsessive-Compulsive Disorder2COVID2Quality of Life2Radiologically Isolated Syndrome2Aging Disorder2Aging, Healthy2Nephrotic Syndrome2Pseudoxanthoma Elasticum2Chronic Myelomonocytic Leukemia2Rheumatoid Arthritis2 Stroke2Dysphagia2Chronic Kidney Diseases2Bariatric Surgery Candidate2Melanoma (Skin)2Friedreich Ataxia2

By trial register

Register	Trials	Recruiting
Clinical trials in France	198	119
Clinical trials in Canada	1	0
Clinical trials in Spain	1	1
Clinical trials in Italy	1	1
Clinical trials in Netherlands	1	1
Clinical trials in Belgium	1	1
EU register (CTIS)	3	—

A trial with sites in more than one country appears in each of those registers; recruiting counts cover the trials listed on this page.

Other sponsors in Aging

Sponsor	Trials
National University of Singapore	5
Chang Gung Memorial Hospital	5
University of Valencia	5
National Health Research Institutes, Taiwan	4
Longevity Metrics	3
Fundacion Miguel Servet	3
Teoxane	2
Westlake University	2
Federal University of Rio Grande do Sul	2
L'Oreal	1

Sponsors with the most current trials registered for this condition.

Questions about Centre Hospitalier Universitaire de Nice trials

How many clinical trials does Centre Hospitalier Universitaire de Nice sponsor?

Centre Hospitalier Universitaire de Nice is the lead sponsor of 198 current trials on ClinicalTrials.gov in our France, Canada, Spain, Italy, Netherlands and Belgium registers, and 3 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.

Are Centre Hospitalier Universitaire de Nice trials recruiting?

Yes. 119 of its 198 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Centre Hospitalier Universitaire de Nice testing?

Its current trials name 28 drugs and biologicals as interventions. The most frequent are Amiloride (1), Amoxicillin (1), Bimekizumab (1), Botulinum toxin (1) and Cholestyramine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.